Transcranial color-coded duplex sonography, magnetic resonance angiography, and computed tomography angiography: methods, applications, advantages, and limitations.

Transcranial color-coded duplex sonography (TCCD), magnetic resonance angiography (MRA), and computed tomography angiography (CTA) are novel noninvasive or minimally invasive techniques for the study of the intracranial circulation. TCCD is relatively inexpensive and permits bedside examination. It improves the accuracy and reliability of conventional transcranial Doppler studies. The main limitation of TCCD are the ultrasonic windows. They restrict the area of insonation to the major cerebral arteries and the proximal part of its branches, lower the spatial resolution, and may prevent transtemporal insonation. Using MRA, both large and small intracranial arteries and veins can be imaged by selecting the appropriate imaging parameters. MRA provides morphologic information about the cerebral vessels, relying on blood flow as the physical basis for generating contrast between stationary tissues and moving spins. MRA is highly sensitive for the detection of occlusive disease in large intracranial arteries. However, with bright blood techniques the degree of stenosis tends to be exaggerated. Flow direction, eg, in collaterals, can be determined by selective or phase-contrast MRA. Perfusion imaging techniques provide information about blood flow at the capillary level. Diffusion imaging depicts molecular motion. TCCD and MRA used in combination or alone may eliminate the need for intra-arterial digital subtraction angiography (DSA) in most patients studied for occlusive cerebrovascular disease. DSA may be reserved for those patients where there is disagreement among the noninvasive techniques, and for the diagnosis of cerebral aneurysms and arteriovenous malformations. CTA relies on spiral CT technology and intravenous contrast injection. To date, intracranial use has been predominantly for the diagnosis of aneurysms. The role of CTA for the detection of nonaneurysmal intracranial vascular disease has yet to be established.